Phosphatidylcholine does not protect rats against 5-fluorouracil/folinic acid-induced damage of the intestinal luminal mucosa

Journal of Cancer Research and Clinical Oncology

Volumn 128, Issue 2, 2002, Pages 80-84

  Fittkau, M ^a   Gerlach, R ^a   Schmoll, H J ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

5 Fluorouracil; Folinic acid; Intestinal peptidases; Perfusion; Phosphatidylcholine

Indexed keywords

FLUOROURACIL; FOLINIC ACID; PEPTIDASE; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GASTROINTESTINAL TOXICITY; INTESTINE INJURY; INTESTINE MUCOSA; INTESTINE PERFUSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; FLUOROURACIL; INFUSIONS, INTRAVENOUS; INTESTINAL MUCOSA; LEUCOVORIN; PHOSPHATIDYLCHOLINES; RATS; RATS, WISTAR;

EID: 0036164856     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-001-0307-0     Document Type: Article

References (40)

1. Polyenylphosphatiylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis
2. Alcohol-induced pancreatic oxidative stress: Protection by phospholipid repletion
3. Polyenylphosphatidylcholine protects against alcohol but not iron-induced oxidative stress in the liver
4. Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects
5. A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma
6. Treatment for advanced colorectal carcinoma with 5-fluorouracil plus low-dose leucovorin
7. Role of biliary phosphatidylcholine in bile acid protection and NSAID injury of the ileal mucosa in rats
8. Phosphorus assay in column chromatography
9. Food induced stimulation of the antisecretory factor can improve symptoms in human inflammatory bowel disease: A study of a concept
10. Effect of polyunsaturated phosphatidylcholine on lipid structure and cAMP-dependent signal transduction in the liver of rats chronically intoxicated with ethanol
11. Hepatic and pancreatic effects of polyenoylphosphatidylcholine in rats with alloxan-induced diabetes
12. Renal dipeptidase
13. Role of fluoropyrimidine schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma
14. Interleukin 15 protects against toxicity and potentiates antitumor activity of 5-fluorouracil alone and in combination with leucovorin in rats bearing colorectal cancer
15. Levamisole/fluorouracil. A review of their pharmacology and adjuvant therapeutic use in colorectal cancer
16. Reduction of chemotherapy-induced sideeffects by parenteral glutamine supplementation in patients with metastatic colorectal cancer
17. Gastroprotective capability of exogenous phosphatidylcholine in experimentally induced chronic gastric ulcers in rats
18. Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: A phase II study
19. 5-Fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma
20. Protective effect of oral phosphatidylcholine on radiation-induced release of intestinal peptidases in rats
21. A low dose of ionizing radiation increases luminal release of intestinal peptidases in rats
22. Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU
23. Beitrag zur eiweissbestimmung in stark verdünnten lösungen
24. Determination of dihydropyrimidine dehydrogenase in the prediction of toxic side effects of 5-fluorouracil
25. Biochemical consequences of 5-fluorouracil gastrointestinal toxicity in rats; effect of high-dose uridine
26. Dipeptidylpeptidase IV-aktivität in serum und synovia bei patienten mit rheumatoider arthritis
27. Pilotstudie mit polyenylphosphatidylcholin bei schwerer leberinsuffizienz
28. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases
29. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon
30. Absorption of di-linoleoylphosphatidylcholine after oral administration
31. Biochemical modulation of fluorouracil with leucovorin: Confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer
32. Chemically-induced apoptosis: p21 and p53 as determinants of enterotoxin activity
33. The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia
34. Toxicity and antitumor activity of 5-fluorouracil in combination with leucovorin
35. Development of treatment for advanced colorectal cancer: Infusional 5-FU and the role of new agents
36. Kolorektales karzinom
37. Where do we stand with 5-fluorouracil?
38. Serum β-glucuronidase determination with p-nitrophenyl-glucuronide
39. Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium